• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Astera Labs Announces Financial Results for the Second Quarter of Fiscal Year 2024

    8/6/24 4:05:00 PM ET
    $ALAB
    Semiconductors
    Technology
    Get the next $ALAB alert in real time by email
    • Record quarterly revenue of $76.9 million, up 18% QoQ and up 619% YoY
    • Multiple secular trends, design wins across diverse AI platform architectures, and increasing average dollar content position the Company to outpace industry growth

     

    Astera Labs, Inc. (NASDAQ:ALAB), a global leader in semiconductor-based connectivity solutions for cloud and AI infrastructure, today announced preliminary financial results for the second quarter of fiscal 2024, ended June 30, 2024.

    "Astera Labs achieved robust top-line growth during Q2, and we expect even stronger sequential growth in the September quarter, fueled by the production ramp of new AI platforms at hyperscalers featuring both third-party and internally developed accelerators," said Jitendra Mohan, Astera Labs' Chief Executive Officer. "Sustained secular trends in AI adoption, design wins across diverse AI platform architectures, and increasing average dollar content in next generation GPU-based AI platforms give us confidence in our ability to outperform industry growth rates. Our close collaboration with hyperscalers and AI platform providers continues to yield valuable insights, unlocking new product and business opportunities for our Intelligent Connectivity Platform, which we believe will drive strong, long-term growth."

    Second Quarter of Fiscal 2024 Financial Highlights

    GAAP Financial Results:

    • Revenue of $76.9 million, up 18% sequentially and up 619% year-over-year
    • GAAP gross margin of 77.9%
    • GAAP operating loss of $24.3 million
    • GAAP net loss of $7.5 million
    • GAAP diluted net loss per share of $0.05

    Non-GAAP Financial Results (excluding the impact of stock-based compensation expense and the income tax effects of non-GAAP adjustments):

    • Non-GAAP gross margin of 78.0%
    • Non-GAAP operating income of $18.7 million
    • Non-GAAP net income of $22.2 million
    • Non-GAAP diluted earnings per share of $0.13

    Second Quarter of Fiscal 2024 and Recent Business Highlights

    • Demonstrated the industry's first end-to-end PCIe optical connectivity link to provide extended reach for larger, disaggregated GPU clusters. PCIe over optics expands Astera Labs' widely deployed and field-tested Aries family of Smart DSP retimers and Smart Cable Modules (SCMs) to deliver robust PCIe and CXL connectivity in chip-to-chip, box-to-box, and rack-to-rack topologies throughout the data center.
    • Announced the expansion of PCIe 6.x testing capabilities with a new Cloud-Scale Interop Lab in Taiwan, accelerating time-to-market for PCIe 6.x AI servers optimized with the recently launched Aries 6 Smart DSP retimers. The new Interop Lab will facilitate closer collaboration with key ODM customers to test Aries 6 in complex PCIe topologies with a broad variety of hosts and endpoints interconnected over varying channel insertion loss budgets in real systems.
    • Announced the intention to expand operations into India with a new R&D site to further scale the organization and strengthen the Company's global footprint. The new site will open in Bangalore later this year and we believe it will help to attract the region's rich engineering talent and resources to support the next phase of growth for Astera Labs.
    • Appointed Bethany Mayer to the Board of Directors, bringing over 30 years of experience as a visionary leader and board member across multiple networking, cybersecurity, and semiconductor companies.

    Third Quarter of Fiscal 2024 Financial Outlook

    Based on current business trends and conditions, we estimate the following:

    GAAP Financial Outlook:

    • Revenue within a range of $95 million to $100 million
    • GAAP gross margin of approximately 75%
    • GAAP operating expenses of within a range of approximately $92 million to $93 million
    • GAAP tax rate of approximately (22%)
    • GAAP diluted loss per share within a range of approximately $0.06 to $0.08 on weighted-average diluted shares outstanding of approximately 155 million

    Non-GAAP Financial Outlook (excluding the impact of approximately $46 million of stock-based compensation and including $5.5 million of additional income taxes):

    • Non-GAAP gross margin of approximately 75%
    • Non-GAAP operating expenses within a range of approximately $46 million to $47 million
    • Non-GAAP tax rate of approximately 20%
    • Non-GAAP diluted earnings per share within a range of approximately $0.16 to $0.17 on weighted-average diluted shares outstanding of approximately 177 million

    Earnings Webcast and Conference Call

    Astera Labs will host a conference call to review its financial results for the second quarter of fiscal 2024 and to discuss our financial outlook today at 1:30 p.m. Pacific Time. Interested parties may join the conference call by dialing 1-800-715-9871 and using conference ID 8761024. The call will also be webcast and can be accessed at the Astera Labs website at https://ir.asteralabs.com/. The webcast will be recorded and available for replay on our website for the next six months.

    Discussion of Non-GAAP Financial Measures

    We use certain non-GAAP financial measures to supplement the performance measures in our consolidated financial statements, which are presented in accordance with GAAP. A reconciliation of these non-GAAP measures to the closest GAAP measure can be found later in this release. These non-GAAP financial measures include non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income (loss), non-GAAP tax rate, non-GAAP net income (loss), non-GAAP diluted earnings (loss) per share, and non-GAAP weighted-average share count. We use these non-GAAP financial measures for financial and operational decision-making and as a means to assist us in evaluating period-to-period comparisons. By excluding certain items that may not be indicative of our recurring core operating results, we believe that, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income (loss), non-GAAP tax rate, non-GAAP net income (loss), pro forma non-GAAP diluted earnings (loss) per share, and pro forma non-GAAP weighted-average share count provide meaningful supplemental information regarding our performance. Accordingly, we believe these non-GAAP financial measures are useful to investors and others because they allow for additional information with respect to financial measures used by management in its financial and operational decision-making and they may be used by our institutional investors and the analyst community to help them analyze the health of our business. However, there are a number of limitations related to the use of non-GAAP financial measures, and these non-GAAP measures should be considered in addition to, not as a substitute for or in isolation from, our financial results prepared in accordance with GAAP. Other companies, including companies in our industry, may calculate these non-GAAP financial measures differently or not at all, which reduces their usefulness as comparative measures. No reconciliation is provided with respect to the forward-looking non-GAAP financial measures included in our non-GAAP financial outlook, as the GAAP measures are not accessible on a forward-looking basis. As a result, we cannot reliably predict all necessary components or their impact to reconcile such financial measures without unreasonable effort. The events necessitating a non-GAAP adjustment are inherently unpredictable and may have a significant impact on our future GAAP financial results.

    We adjust the following items from one or more of our non-GAAP financial measures:

    Stock-based compensation expense

    We exclude stock-based compensation expense, which is a non-cash expense, from certain of our non-GAAP financial measures because we believe that excluding this item provides meaningful supplemental information regarding operational performance. In particular, companies calculate non-cash stock-based compensation expense using a variety of valuation methodologies and subjective assumptions. Moreover, stock-based compensation expense is a non-cash charge that can vary significantly from period to period for reasons that are unrelated to our core operating performance, and therefore excluding this item provides investors and other users of our financial information with information that allows meaningful comparison of our business performance across periods.

    Employer payroll taxes related to stock-based compensation resulting from our IPO

    We exclude employer payroll taxes related to the time-based vesting and net settlement of restricted stock units in connection with our initial public offering (the "IPO"), because this does not correlate to the operation of our business. We believe that excluding this item provides meaningful supplemental information regarding operational performance given the amount of employer payroll tax-related items on employee stock transactions was immaterial prior to our IPO.

    Income Tax effect

    This represents the impact of the non-GAAP adjustments on an after-tax basis in connection with the presentation of non-GAAP net income (loss) and non-GAAP net income (loss) per diluted share. This approach is designed to enhance investors' ability to understand the impact of our non-GAAP tax expense on its current operations, provide improved modeling accuracy, and substantially reduce fluctuations caused by GAAP to non-GAAP adjustments.

    Pro-forma non-GAAP weighted-average shares to compute non-GAAP net income (loss)

    We present pro-forma non-GAAP weighted-average shares, assuming the redeemable convertible preferred stock is converted from the beginning of each respective periods presented, to provide meaningful supplemental information regarding EPS trend on a consistent basis. All of our outstanding redeemable preferred stock converted into the equivalent number of shares of common stock in connection with our IPO.

    Cautionary Note Regarding Forward-Looking Statements

    This press release contains forward-looking statements based on Astera Labs' current expectations. The words "believe", "estimate", "expect", "intend", "anticipate", "plan", "project", "will", and similar phrases as they relate to Astera Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Astera Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. These forward-looking statements include but are not limited to, statements regarding our future operating results, financial position and guidance, our business strategy and plans, our objectives for future operations, including the success of our global footprint expansion, our development or delivery of new or enhanced products and anticipated results of those products for our customers, our competitive positioning, technological capabilities and plans, and macroeconomic trends in cloud and AI infrastructure. A variety of risks and factors that are beyond our control could cause actual results to differ materially from those in the forward-looking statements including, without limitation: the competitive and cyclical nature of the semiconductor industry; the concentration of our customer base; the continued demand for AI; the challenging macroeconomic environment, including disruptions in the financial services industry; risks that demand and the supply chain may be adversely affected, including by military conflict (such as between Russia/Ukraine and Israel/Hamas), terrorism, sanctions or other geopolitical events globally (including conflict between Taiwan and China); quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with managing international activities (including trade barriers, particularly with respect to China); absence of long-term commitments from customers; risks that Astera Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; stock price volatility; information technology risks, including cyber-attacks against Astera Labs' products and its networks; and other risks and uncertainties that are detailed under the caption "Risk Factors" and elsewhere in our Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") and the other SEC filings and reports Astera Labs may make from time to time. Moreover, we operate in a very competitive and rapidly changing environment, and new risks may emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor(s) may cause actual results or outcomes to differ materially from those contained in any forward-looking statements we may make. Accordingly, you should not rely on any of the forward-looking statements. Astera Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

    About Astera Labs

    Our PCIe, CXL and Ethernet semiconductor-based connectivity solutions are purpose-built to unleash the full potential of accelerated computing at cloud-scale. Inspired by trusted partnerships with hyperscalers and the data center ecosystem, we are an innovation leader of products that are customizable, interoperable, and reliable. Discover how we are transforming AI and modern data-driven applications at www.asteralabs.com.

    ASTERA LABS, INC.

     

    CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

    (In thousands)

     

     

     

    June 30,

    2024

     

    December 31,

    2023

    Assets

     

     

     

     

    Current assets

     

     

     

     

    Cash and cash equivalents

     

    $

    421,076

     

     

    $

    45,098

     

    Marketable securities

     

     

    409,919

     

     

     

    104,215

     

    Accounts receivable, net

     

     

    22,233

     

     

     

    8,335

     

    Inventory

     

     

    28,572

     

     

     

    24,095

     

    Prepaid expenses and other current assets

     

     

    9,445

     

     

     

    4,064

     

    Total current assets

     

     

    891,245

     

     

     

    185,807

     

    Property and equipment, net

     

     

    21,821

     

     

     

    4,712

     

    Other assets

     

     

    2,449

     

     

     

    5,773

     

    Total assets

     

    $

    915,515

     

     

    $

    196,292

     

     

     

     

     

     

    Liabilities, Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)

     

     

     

     

    Current liabilities

     

     

     

     

    Accounts payable

     

    $

    14,595

     

     

    $

    6,337

     

    Accrued expenses and other current liabilities

     

     

    49,478

     

     

     

    28,742

     

    Total current liabilities

     

     

    64,073

     

     

     

    35,079

     

    Other liabilities

     

     

    6,190

     

     

     

    3,787

     

    Total liabilities

     

     

    70,263

     

     

     

    38,866

     

    Commitments and contingencies

     

     

     

     

    Redeemable convertible preferred stock

     

     

    —

     

     

     

    255,127

     

    Stockholders' equity (deficit)

     

     

     

     

    Common stock

     

     

    16

     

     

     

    4

     

    Additional paid-in capital

     

     

    1,071,504

     

     

     

    27,411

     

    Accumulated other comprehensive (loss) income

     

     

    (352

    )

     

     

    259

     

    Accumulated deficit

     

     

    (225,916

    )

     

     

    (125,375

    )

    Total stockholders' equity (deficit)

     

     

    845,252

     

     

     

    (97,701

    )

    Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)

     

    $

    915,515

     

     

    $

    196,292

     

    ASTERA LABS, INC.

     

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

    (In thousands, except per share amounts)

     

     

     

    Three Months Ended

     

    Six Months Ended

     

     

    June 30,

    2024

     

    March 31,

    2024

     

    June 30,

    2023

     

    June 30,

    2024

     

    June 30,

    2023

    Revenue

     

    $

    76,850

     

     

    $

    65,258

     

     

    $

    10,688

     

     

    $

    142,108

     

     

    $

    28,352

     

    Cost of revenue

     

     

    16,996

     

     

     

    14,738

     

     

     

    2,249

     

     

     

    31,734

     

     

     

    15,655

     

    Gross profit

     

     

    59,854

     

     

     

    50,520

     

     

     

    8,439

     

     

     

    110,374

     

     

     

    12,697

     

     

     

     

     

     

     

     

     

     

     

     

    Operating expenses

     

     

     

     

     

     

     

     

     

     

    Research and development

     

     

    40,089

     

     

     

    53,558

     

     

     

    17,860

     

     

     

    93,647

     

     

     

    33,127

     

    Sales and marketing

     

     

    22,076

     

     

     

    55,510

     

     

     

    5,097

     

     

     

    77,586

     

     

     

    9,490

     

    General and administrative

     

     

    22,036

     

     

     

    24,419

     

     

     

    3,095

     

     

     

    46,455

     

     

     

    6,620

     

    Total operating expenses

     

     

    84,201

     

     

     

    133,487

     

     

     

    26,052

     

     

     

    217,688

     

     

     

    49,237

     

    Operating loss

     

     

    (24,347

    )

     

     

    (82,967

    )

     

     

    (17,613

    )

     

     

    (107,314

    )

     

     

    (36,540

    )

    Interest income

     

     

    10,264

     

     

     

    2,554

     

     

     

    1,555

     

     

     

    12,818

     

     

     

    3,151

     

    Loss before income taxes

     

     

    (14,083

    )

     

     

    (80,413

    )

     

     

    (16,058

    )

     

     

    (94,496

    )

     

     

    (33,389

    )

    Income tax (benefit) provision

     

     

    (6,537

    )

     

     

    12,582

     

     

     

    3,946

     

     

     

    6,045

     

     

     

    4,069

     

    Net loss

     

    $

    (7,546

    )

     

    $

    (92,995

    )

     

    $

    (20,004

    )

     

    $

    (100,541

    )

     

    $

    (37,458

    )

     

     

     

     

     

     

     

     

     

     

     

    Net loss per share attributable to common stockholders:

     

     

     

     

    Basic and diluted

     

    $

    (0.05

    )

     

    $

    (1.77

    )

     

    $

    (0.55

    )

     

    $

    (0.97

    )

     

    $

    (1.03

    )

    Weighted-average shares used in calculating net loss per share attributable to common stockholders:

     

     

     

     

     

     

     

     

     

     

    Basic and diluted

     

     

    155,199

     

     

     

    52,532

     

     

     

    36,567

     

     

     

    103,865

     

     

     

    36,199

     

    ASTERA LABS, INC.

     

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

    (In thousands)

     

     

     

    Six Months Ended

     

     

    June 30,

    2024

     

    June 30,

    2023

    Cash flows from operating activities

     

     

     

     

    Net loss

     

    $

    (100,541

    )

     

    $

    (37,458

    )

    Adjustments to reconcile net loss to net cash provided by (used in) operating activities

     

     

     

     

    Stock-based compensation

     

     

    140,835

     

     

     

    4,669

     

    Inventory write-downs

     

     

    1,493

     

     

     

    9,733

     

    Depreciation

     

     

    1,331

     

     

     

    763

     

    Non-cash operating lease expense

     

     

    1,106

     

     

     

    536

     

    Warrants contra revenue

     

     

    443

     

     

     

    127

     

    Accretion of discounts on marketable securities

     

     

    (1,637

    )

     

     

    (640

    )

    Changes in operating assets and liabilities:

     

     

     

     

    Accounts receivable, net

     

     

    (13,898

    )

     

     

    9,081

     

    Inventory

     

     

    (5,970

    )

     

     

    1,374

     

    Prepaid expenses and other assets

     

     

    (5,396

    )

     

     

    223

     

    Accounts payable

     

     

    5,831

     

     

     

    (7,745

    )

    Accrued expenses and other liabilities

     

     

    10,930

     

     

     

    (6,844

    )

    Operating lease liability

     

     

    (1,062

    )

     

     

    (600

    )

    Net cash provided by (used in) operating activities

     

     

    33,465

     

     

     

    (26,781

    )

     

     

     

     

     

    Cash flows from investing activities

     

     

     

     

    Purchases of property and equipment

     

     

    (2,100

    )

     

     

    (1,014

    )

    Purchases of marketable securities

     

     

    (345,756

    )

     

     

    (27,274

    )

    Maturities of marketable securities

     

     

    20,776

     

     

     

    18,000

     

    Sales of marketable securities

     

     

    20,358

     

     

     

    54,749

     

    Net cash (used in) provided by investing activities

     

     

    (306,722

    )

     

     

    44,461

     

     

     

     

     

     

    Cash flows from financing activities

     

     

     

     

    Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions

     

     

    672,198

     

     

     

    —

     

    Payment of deferred offering costs

     

     

    (4,801

    )

     

     

    —

     

    Tax withholding related to net share settlements of restricted stock units

     

     

    (20,111

    )

     

     

    —

     

    Proceeds (payments) from exercises of stock options, net of repurchases

     

     

    1,949

     

     

     

    (87

    )

    Net cash provided by (used in) financing activities

     

     

    649,235

     

     

     

    (87

    )

    Net increase in cash and cash equivalents

     

     

    375,978

     

     

     

    17,593

     

    Cash and cash equivalents

     

     

     

     

    Beginning of the period

     

     

    45,098

     

     

     

    76,088

     

    End of the period

     

    $

    421,076

     

     

    $

    93,681

     

    ASTERA LABS, INC.

     

    RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (Unaudited)

    (In thousands, except percentages and per share amounts)

     

     

     

    Three Months Ended

     

    Six Months Ended

     

     

    June 30,

    2024

     

    March 31,

    2024

     

    June 30,

    2023

     

    June 30,

    2024

     

    June 30,

    2023

    GAAP gross profit

     

    $

    59,854

     

     

    $

    50,520

     

     

    $

    8,439

     

     

    $

    110,374

     

     

    $

    12,697

     

    Stock-based compensation expense upon IPO (1)

     

     

    —

     

     

     

    516

     

     

     

    —

     

     

     

    516

     

     

     

    —

     

    Stock-based compensation expense

     

     

    84

     

     

     

    12

     

     

     

    2

     

     

     

    96

     

     

     

    7

     

    Non-GAAP gross profit

     

    $

    59,938

     

     

    $

    51,048

     

     

    $

    8,441

     

     

    $

    110,986

     

     

    $

    12,704

     

     

     

     

     

     

     

     

     

     

     

     

    GAAP gross margin

     

     

    77.9

    %

     

     

    77.4

    %

     

     

    79.0

    %

     

     

    77.7

    %

     

     

    44.8

    %

    Stock-based compensation expense upon IPO (1)

     

     

    —

     

     

     

    0.8

     

     

     

    —

     

     

     

    0.3

     

     

     

    —

     

    Stock-based compensation expense

     

     

    0.1

     

     

     

    —

     

     

     

    —

     

     

     

    0.1

     

     

     

    —

     

    Non-GAAP gross margin

     

     

    78.0

    %

     

     

    78.2

    %

     

     

    79.0

    %

     

     

    78.1

    %

     

     

    44.8

    %

     

     

     

     

     

     

     

     

     

     

     

    GAAP operating loss

     

    $

    (24,347

    )

     

    $

    (82,967

    )

     

    $

    (17,613

    )

     

    $

    (107,314

    )

     

    $

    (36,540

    )

    Stock-based compensation expense upon IPO (1)

     

     

    —

     

     

     

    88,873

     

     

     

    —

     

     

     

    88,873

     

     

     

    —

     

    Stock-based compensation expense

     

     

    43,067

     

     

     

    8,895

     

     

     

    2,672

     

     

     

    51,962

     

     

     

    4,669

     

    Employer payroll tax related to stock-based compensation from IPO (2)

     

     

    —

     

     

     

    1,072

     

     

     

    —

     

     

     

    1,072

     

     

     

    —

     

    Non-GAAP operating income (loss)

     

    $

    18,720

     

     

    $

    15,873

     

     

    $

    (14,941

    )

     

    $

    34,593

     

     

    $

    (31,871

    )

     

     

     

     

     

     

     

     

     

     

     

    GAAP net loss

     

    $

    (7,546

    )

     

    $

    (92,995

    )

     

    $

    (20,004

    )

     

    $

    (100,541

    )

     

    $

    (37,458

    )

    Stock-based compensation expense upon IPO (1)

     

     

    —

     

     

     

    88,873

     

     

     

    —

     

     

     

    88,873

     

     

     

    —

     

    Stock-based compensation expense

     

     

    43,067

     

     

     

    8,895

     

     

     

    2,672

     

     

     

    51,962

     

     

     

    4,669

     

    Employer payroll tax related to stock-based compensation from IPO (2)

     

     

    —

     

     

     

    1,072

     

     

     

    —

     

     

     

    1,072

     

     

     

    —

     

    Income tax effect (3)

     

     

    (13,296

    )

     

     

    8,485

     

     

     

    —

     

     

     

    (4,811

    )

     

     

    —

     

    Non-GAAP net income (loss)

     

    $

    22,225

     

     

    $

    14,330

     

     

    $

    (17,332

    )

     

    $

    36,555

     

     

    $

    (32,789

    )

     

     

     

     

     

     

     

     

     

     

     

    Net (loss) income per share attributable to common stockholders:

     

     

     

     

    GAAP - basic and diluted

     

    $

    (0.05

    )

     

    $

    (1.77

    )

     

    $

    (0.55

    )

     

    $

    (0.97

    )

     

    $

    (1.03

    )

    Pro forma Non-GAAP - diluted

     

    $

    0.13

     

     

    $

    0.10

     

     

    $

    (0.14

    )

     

    $

    0.23

     

     

    $

    (0.26

    )

     

     

     

     

     

     

     

     

     

     

     

    Weighted average shares used to compute net loss per share attributable to common stockholders:

     

     

     

     

    GAAP - basic and diluted

     

     

    155,199

     

     

     

    52,532

     

     

     

    36,567

     

     

     

    103,865

     

     

     

    36,199

     

    Pro forma Non-GAAP - diluted (4)

     

     

    175,279

     

     

     

    147,514

     

     

     

    127,458

     

     

     

    162,378

     

     

     

    127,090

     

    _______________________

    (1) Stock-based compensation expense recognized in connection with the time-based vesting and settlement of RSUs that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

    (2) Employer payroll taxes related to the time-based vesting and settlement of RSUs, that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

    (3) The income tax effect represents the impact of the non-GAAP adjustments on an after-tax basis in connection with the presentation of non-GAAP net income (loss) and non-GAAP net income (loss) per diluted share. For the three months ended June 30, 2024 and March 31, 2024, the non-GAAP tax rates were approximately of 23% and 22%, respectively. For the six months ended June 30, 2024, the non-GAAP tax rate was approximately 23%. The adjustments for the three and six months ended June 30, 2023 were not material.

    (4) We present the pro-forma non-GAAP weighted average shares to provide meaningful supplemental information of comparable shares for each periods presented. The pro forma weighted average shares is calculated as follows:

     

     

    Three Months Ended

     

    Six Months Ended

     

     

    June 30,

    2024

     

    March 31,

    2024

     

    June 30,

    2023

     

    June 30,

    2024

     

    June 30,

    2023

    Shares used to compute GAAP net loss per share attributable to common stockholders - diluted

     

    155,199

     

    52,532

     

    36,567

     

    103,865

     

    36,199

    Weighted average effect of the assumed conversion of redeemable convertible preferred stock from the beginning of the periods

     

    —

     

    78,905

     

    90,891

     

    40,451

     

    90,891

    Effect of dilutive equivalent shares

     

    20,080

     

    16,077

     

    —

     

    18,062

     

    —

    Shares used to compute pro forma non-GAAP net income (loss) per share- diluted

     

    175,279

     

    147,514

     

    127,458

     

    162,378

     

    127,090

    ASTERA LABS, INC.

     

    SUPPLEMENTAL FINANCIAL INFORMATION

    STOCK-BASED COMPENSATION EXPENSE (Unaudited)

    (In thousands)

     

     

    Three Months Ended

     

    Six Months Ended

     

    June 30,

    2024

     

    March 31,

    2024

     

    June 30,

    2023

     

    June 30,

    2024

     

    June 30,

    2023

    Cost of revenue

    $

    84

     

    $

    528

     

    $

    2

     

    $

    612

     

    $

    7

    Research and development

     

    12,971

     

     

    30,007

     

     

    1,672

     

     

    42,978

     

     

    3,351

    Sales and marketing

     

    15,758

     

     

    49,258

     

     

    694

     

     

    65,016

     

     

    695

    General and administrative

     

    14,254

     

     

    17,975

     

     

    304

     

     

    32,229

     

     

    616

    Total stock-based compensation expense (1)

    $

    43,067

     

    $

    97,768

     

    $

    2,672

     

    $

    140,835

     

    $

    4,669

    ____________________

    (1) Stock-based compensation expense recognized during the three months ended March 31, 2024 and six months ended June 30, 2024 included $88.9 million of cumulative stock-based compensation expense related to the time-based vesting and settlement of RSUs that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240806374053/en/

    Get the next $ALAB alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALAB

    DatePrice TargetRatingAnalyst
    10/20/2025$155.00Overweight → Equal Weight
    Barclays
    10/3/2025$230.00Neutral
    BofA Securities
    10/1/2025$200.00Hold
    TD Cowen
    7/22/2025$120.00Outperform → Market Perform
    Northland Capital
    5/22/2025Outperform
    William Blair
    5/16/2025$80.00Neutral
    Susquehanna
    5/12/2025$99.00Equal-Weight → Overweight
    Morgan Stanley
    3/14/2025$82.00Outperform
    Raymond James
    More analyst ratings

    $ALAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Astera Labs downgraded by Barclays with a new price target

    Barclays downgraded Astera Labs from Overweight to Equal Weight and set a new price target of $155.00

    10/20/25 8:37:05 AM ET
    $ALAB
    Semiconductors
    Technology

    BofA Securities initiated coverage on Astera Labs with a new price target

    BofA Securities initiated coverage of Astera Labs with a rating of Neutral and set a new price target of $230.00

    10/3/25 9:34:28 AM ET
    $ALAB
    Semiconductors
    Technology

    TD Cowen initiated coverage on Astera Labs with a new price target

    TD Cowen initiated coverage of Astera Labs with a rating of Hold and set a new price target of $200.00

    10/1/25 8:31:27 AM ET
    $ALAB
    Semiconductors
    Technology

    $ALAB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Astera Labs to Acquire aiXscale Photonics

    SAN JOSE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced that it has entered into a definitive agreement to acquire aiXscale Photonics GmbH. The acquisition is expected to help enable Astera Labs to develop photonic scale-up solutions by combining aiXscale's fiber-chip coupling technologies with Astera Labs' connectivity and signal processing portfolio. The transaction is subject to customary closing conditions. The evolution to AI Infrastructure 2.0 demands scale-up connectivity solutions that meet aggressive speed, power, and reliability requirements while

    10/22/25 4:04:47 PM ET
    $ALAB
    Semiconductors
    Technology

    Astera Labs Joins Arm Total Design to Accelerate Custom AI Infrastructure Solutions

    SAN JOSE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced it has joined Arm® Total Design, a comprehensive ecosystem dedicated to accelerating and simplifying custom SoC development based on Arm Neoverse™ Compute Subsystems (CSS). This collaboration will combine Astera Labs' Intelligent Connectivity Platform ecosystem with Arm Neoverse CSS to enable chiplet solutions that meet the growing demand for custom AI infrastructure. The complex integration requirements of rack-scale AI infrastructure are driving a shift toward chiplet-based designs. As AI workloads d

    10/14/25 12:30:00 PM ET
    $ALAB
    Semiconductors
    Technology

    Astera Labs Showcases Rack-Scale AI Ecosystem Momentum at OCP Global Summit

    SAN JOSE, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced from the 2025 OCP Global Summit comprehensive ecosystem collaborations that demonstrate growing industry momentum around open standards for AI Infrastructure 2.0—where entire racks function as unified computing platforms rather than collections of individual servers. Through live demonstrations and technical sessions, Astera Labs will showcase the breadth of support for solutions built with PCIe, UALink, Ethernet, CXL, and OpenBMC standards. "The AI infrastructure landscape is rapidly evolving from ser

    10/13/25 9:00:00 AM ET
    $ALAB
    Semiconductors
    Technology

    $ALAB
    SEC Filings

    View All

    $ALAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Astera Labs Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Astera Labs, Inc. (0001736297) (Filer)

    10/22/25 4:03:06 PM ET
    $ALAB
    Semiconductors
    Technology

    SEC Form 144 filed by Astera Labs Inc.

    144 - Astera Labs, Inc. (0001736297) (Subject)

    9/2/25 4:38:20 PM ET
    $ALAB
    Semiconductors
    Technology

    SEC Form 144 filed by Astera Labs Inc.

    144 - Astera Labs, Inc. (0001736297) (Subject)

    9/2/25 4:38:01 PM ET
    $ALAB
    Semiconductors
    Technology

    General Counsel and Secretary Mazzara Philip sold $1,921,572 worth of shares (10,000 units at $192.16), decreasing direct ownership by 6% to 151,573 units (SEC Form 4)

    4 - Astera Labs, Inc. (0001736297) (Issuer)

    10/3/25 4:30:25 PM ET
    $ALAB
    Semiconductors
    Technology

    Chief Financial Officer Tate Michael Truett gifted 7,000 shares (SEC Form 4)

    4 - Astera Labs, Inc. (0001736297) (Issuer)

    9/12/25 4:15:24 PM ET
    $ALAB
    Semiconductors
    Technology

    Director Alba Manuel sold $31,707,713 worth of shares (183,000 units at $173.27) (SEC Form 4)

    4 - Astera Labs, Inc. (0001736297) (Issuer)

    9/4/25 7:08:20 PM ET
    $ALAB
    Semiconductors
    Technology

    $ALAB
    Financials

    Live finance-specific insights

    View All

    Astera Labs Announces Conference Call to Review Third Quarter 2025 Financial Results

    SANTA CLARA, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced that it will release its financial results for the third quarter 2025 after the close of market on Tuesday, Nov. 4, 2025. Astera Labs will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. Conference Call DetailsDate:Nov. 4, 2025Time:1:30 pm PT / 4:30 pm ETHosts:Jitendra Mohan, Chief Executive Officer Sanjay Gajendra, President and Chief Operating Officer Mike Tate, Chief Financial OfficerDial-in:(800) 715-9871 Conference ID: 5908687Webcast:https://ir.asteralabs.

    10/7/25 4:05:00 PM ET
    $ALAB
    Semiconductors
    Technology

    Astera Labs Announces Conference Call to Review Second Quarter 2025 Financial Results

    SANTA CLARA, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced that it will release its financial results for the second quarter 2025 after the close of market on Tuesday, Aug. 5, 2025. Astera Labs will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. Conference Call DetailsDate: Aug. 5, 2025Time:1:30 pm PT / 4:30 pm ET Hosts:Jitendra Mohan, Chief Executive Officer Sanjay Gajendra, President and Chief Operating Officer Mike Tate, Chief Financial OfficerDial-in: (800) 715-9871 Conference ID: 5908687Webcast:https://ir.a

    7/8/25 4:05:00 PM ET
    $ALAB
    Semiconductors
    Technology

    Astera Labs Announces Conference Call to Review First Quarter 2025 Financial Results

    SANTA CLARA, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced that it will release its financial results for the first quarter 2025 after the close of market on Tuesday, May 6, 2025. Astera Labs will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. Conference Call Details Date:May 6, 2025  Time:1:30 pm PT / 4:30 pm ET  Hosts:Jitendra Mohan, Chief Executive OfficerSanjay Gajendra, President and Chief Operating OfficerMike Tate, Chief Financial Officer  Dial-in:(800) 715-9871Conference ID: 5908687  Webcast:https://ir

    4/10/25 4:05:00 PM ET
    $ALAB
    Semiconductors
    Technology

    $ALAB
    Leadership Updates

    Live Leadership Updates

    View All

    Astera Labs Appoints Dr. Craig Barratt to Board of Directors

    SANTA CLARA, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced the appointment of Dr. Craig Barratt to its Board of Directors. Dr. Barratt is a seasoned technology industry veteran with decades of experience as an impactful leader and board member at networking, semiconductor, and medical device companies. "Craig's proven track record of scaling high-growth technology companies and driving breakthrough innovations at industry leaders like Atheros, Google, and Qualcomm makes him an invaluable addition to Astera Labs' Board of Directors," said Jitendra Moh

    3/3/25 4:05:00 PM ET
    $ALAB
    $ISRG
    Semiconductors
    Technology
    Industrial Specialties
    Health Care

    Astera Labs Appoints Bethany Mayer to Board of Directors

    Mayer brings technology and leadership expertise in scaling multi-billion-dollar enterprises Astera Labs, Inc. (NASDAQ:ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced the appointment of Bethany Mayer to its Board of Directors. Mayer brings over 30 years of experience as a visionary leader and board member at networking, cybersecurity, and semiconductor companies. "Bethany brings a wide range of technology and leadership experiences at both global corporations and tech start-ups to Astera Labs, and we are pleased to welcome her to the Board of Directors," said Jitendra Mohan, CEO and Co-founder, Astera Labs. "Her exper

    6/24/24 4:30:00 PM ET
    $ALAB
    Semiconductors
    Technology

    $ALAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Astera Labs Inc.

    SC 13G - Astera Labs, Inc. (0001736297) (Subject)

    11/19/24 5:17:17 PM ET
    $ALAB
    Semiconductors
    Technology

    SEC Form SC 13G filed by Astera Labs Inc.

    SC 13G - Astera Labs, Inc. (0001736297) (Subject)

    11/19/24 5:10:50 PM ET
    $ALAB
    Semiconductors
    Technology

    SEC Form SC 13G filed by Astera Labs Inc.

    SC 13G - Astera Labs, Inc. (0001736297) (Subject)

    11/14/24 4:11:12 PM ET
    $ALAB
    Semiconductors
    Technology